1 Ocak 2019 Dergi makalesi Açık Erişim

Ebrahimi, Ayyub; Sevinc, Kenan; Sevinc, Gulben Gurhan; Cribbs, Adam P.; Philpott, Martin; Uyulur, Firat; Morova, Tunc; Dunford, James E.; Goklemez, Sencer; Ari, Sule; Oppermann, Udo; Onder, Tamer T.

MARC21 XML

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="http://www.loc.gov/MARC21/slim">
  <leader>00000nam##2200000uu#4500</leader>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Bromodomain inhibition of the coactivators CBP/EP300 facilitate cellular reprogramming</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="4">
    <subfield code="p">NATURE CHEMICAL BIOLOGY</subfield>
    <subfield code="v">15</subfield>
    <subfield code="n">5</subfield>
    <subfield code="c">519-+</subfield>
  </datafield>
  <controlfield tag="001">72505</controlfield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">user-tubitak-destekli-proje-yayinlari</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">Silencing of the somatic cell type-specific genes is a critical yet poorly understood step in reprogramming. To uncover pathways that maintain cell identity, we performed a reprogramming screen using inhibitors of chromatin factors. Here, we identify acetyl-lysine competitive inhibitors targeting the bromodomains of coactivators CREB (cyclic-AMP response element binding protein) binding protein (CBP) and E1A binding protein of 300 kDa (EP300) as potent enhancers of reprogramming. These inhibitors accelerate reprogramming, are critical during its early stages and, when combined with DOT1L inhibition, enable efficient derivation of human induced pluripotent stem cells (iPSCs) with OCT4 and SOX2. In contrast, catalytic inhibition of CBP/EP300 prevents iPSC formation, suggesting distinct functions for different coactivator domains in reprogramming. CBP/EP300 bromodomain inhibition decreases somatic-specific gene expression, histone H3 lysine 27 acetylation (H3K27Ac) and chromatin accessibility at target promoters and enhancers. The master mesenchymal transcription factor PRRX1 is one such functionally important target of CBP/EP300 bromodomain inhibition. Collectively, these results show that CBP/EP300 bromodomains sustain cell-type-specific gene expression and maintain cell identity.</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="2">opendefinition.org</subfield>
    <subfield code="a">cc-by</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Koc Univ, Sch Med, Istanbul, Turkey</subfield>
    <subfield code="a">Sevinc, Kenan</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Koc Univ, Sch Med, Istanbul, Turkey</subfield>
    <subfield code="a">Sevinc, Gulben Gurhan</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Univ Oxford, Oxford NIHR BRU, Botnar Res Ctr, Oxford, England</subfield>
    <subfield code="a">Cribbs, Adam P.</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Univ Oxford, Oxford NIHR BRU, Botnar Res Ctr, Oxford, England</subfield>
    <subfield code="a">Philpott, Martin</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Koc Univ, Sch Med, Istanbul, Turkey</subfield>
    <subfield code="a">Uyulur, Firat</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Koc Univ, Sch Med, Istanbul, Turkey</subfield>
    <subfield code="a">Morova, Tunc</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Univ Oxford, Oxford NIHR BRU, Botnar Res Ctr, Oxford, England</subfield>
    <subfield code="a">Dunford, James E.</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Koc Univ, Sch Med, Istanbul, Turkey</subfield>
    <subfield code="a">Goklemez, Sencer</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Istanbul Univ, Fac Sci, Dept Mol Biol &amp; Genet, Istanbul, Turkey</subfield>
    <subfield code="a">Ari, Sule</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Oppermann, Udo</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Koc Univ, Sch Med, Istanbul, Turkey</subfield>
    <subfield code="a">Onder, Tamer T.</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="b">article</subfield>
    <subfield code="a">publication</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">Ebrahimi, Ayyub</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2019-01-01</subfield>
  </datafield>
  <controlfield tag="005">20210316034421.0</controlfield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="o">oai:zenodo.org:72505</subfield>
    <subfield code="p">user-tubitak-destekli-proje-yayinlari</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="z">md5:6c3c1acce6b8e1ba4df9f0bef2e03bf1</subfield>
    <subfield code="s">284</subfield>
    <subfield code="u">https://aperta.ulakbim.gov.trrecord/72505/files/bib-8b7d7d99-6159-4554-99f7-3b4e7d85d7f3.txt</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="u">http://www.opendefinition.org/licenses/cc-by</subfield>
    <subfield code="a">Creative Commons Attribution</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.1038/s41589-019-0264-z</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
</record>